nomifensine has been researched along with Hyperprolactinemia in 6 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A group of 17 hyperprolactinemic women was given 200 mg of nomifensine orally to evaluate its diagnostic potential to discriminate between tumors and nontumorous hyperprolactinemia." | 7.66 | Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica. ( Ablanedo, J; Canales, ES; Cano, C; Zárate, A, 1981) |
| "To verify the diagnostic capacity of some dynamic tests of the prolactin (Prl) secretion, the findings obtained by high-resolution computed tomography (CT) were compared with results obtained from tests using nomifensine (NOM) domperidone (DOM) and thyrotrophin-releasing hormone (TRH) in 72 patients with pathological hyperprolactinaemia." | 3.67 | Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia. ( Bianchi, SD; Camanni, F; Ciccarelli, E; Gatti, G; Ghigo, E; Massara, F; Molinatti, GM; Müller, EE, 1986) |
| "A group of 17 hyperprolactinemic women was given 200 mg of nomifensine orally to evaluate its diagnostic potential to discriminate between tumors and nontumorous hyperprolactinemia." | 3.66 | Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica. ( Ablanedo, J; Canales, ES; Cano, C; Zárate, A, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canales, ES | 1 |
| Cano, C | 1 |
| Ablanedo, J | 1 |
| Zárate, A | 1 |
| Takeda, R | 1 |
| Minagawa, F | 1 |
| Nakabayashi, H | 1 |
| Ghigo, E | 1 |
| Ciccarelli, E | 1 |
| Bianchi, SD | 1 |
| Gatti, G | 1 |
| Molinatti, GM | 1 |
| Massara, F | 1 |
| Müller, EE | 1 |
| Camanni, F | 1 |
| Aguirre Sánchez-Covisa, M | 1 |
| Ruiz-Valdepeñas, MP | 1 |
| Larrodera, L | 1 |
| Jaunsolo, MA | 1 |
| Hawkins, FG | 1 |
| Melloni, GF | 1 |
| Catenazzo, G | 1 |
| Torri, A | 1 |
| Fiorenza, AM | 1 |
| Melloni, R | 1 |
| Scarazatti, E | 1 |
| Pontiroli, AE | 1 |
| Falsetti, L | 1 |
1 review available for nomifensine and Hyperprolactinemia
| Article | Year |
|---|---|
[Differential diagnosis of hyperprolactinemia].
Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Humans; Hyperprolactinemia; Levodopa; Nomifensine; | 1986 |
5 other studies available for nomifensine and Hyperprolactinemia
| Article | Year |
|---|---|
Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica.
Topics: Adenoma; Adult; Diagnosis, Differential; Female; Humans; Hyperprolactinemia; Nomifensine; Pituitary | 1981 |
Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia.
Topics: Adenoma; Adolescent; Adult; Domperidone; Female; Humans; Hyperprolactinemia; Hypothalamo-Hypophyseal | 1986 |
[The metoclopramide and nomifensine tests in the diagnosis of prolactinomas].
Topics: Diagnosis, Differential; Female; Humans; Hyperprolactinemia; Male; Metoclopramide; Nomifensine; Pitu | 1986 |
[Radio-hormonal study (radioimmunoassay) in young women with functional hyperprolactinemia. 1) Analysis in basal states].
Topics: Adult; Gonadotropin-Releasing Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Nomifensine; | 1985 |
More on nomifensine.
Topics: Adenoma; Female; Humans; Hyperprolactinemia; Nomifensine; Pituitary Neoplasms | 1985 |